FIELD: medicine, therapy.
SUBSTANCE: invention relates to applying (R)-3-hydroxybutyrate cyclic ester of the formula (1) given in the description of invention. This compound is used for treatment of morbid states mediated by free radicals, toxic agents, such as peptides and proteins and genetic defects that are harmful for metabolism in cell, resistance to insulin or other defects in metabolism of glucose or states causing defect, ischemia, head traumas and/or for enhancing effectiveness in cell activity. Compound of the formula (1) elicits the enhanced effectiveness in elevating the level of (R)-3-hydroxybutyric acid, maintenance of its enhanced level for some hours, possibility of administration without counter-ion and simple method for preparing.
EFFECT: valuable medicinal properties of compositions.
16 cl, 1 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
| COMPOSITIONS AND METHODS FOR ELEVATING AND SUSTAINING KETOSIS | 2014 |
|
RU2659386C2 |
| THERAPEUTIC COMPOSITIONS | 1998 |
|
RU2224510C2 |
| PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
| KETOGENIC COMPOSITION | 2021 |
|
RU2769242C1 |
| PREVENTION AND TREATMENT OF MIGRAINE | 2017 |
|
RU2753057C2 |
| DIAGNOSTICS BASED UPON TETRAZOLIUM COMPOUNDS | 1999 |
|
RU2225004C2 |
| ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL FORMED BY MEDIUM-CHAIN FATTY ACIDS AND COMPOSITIONS AND METHODS BASED ON THEM | 2017 |
|
RU2761829C2 |
| DIAGNOSTIC TESTS BASED ON TETRAZOLIUM COMPOUNDS | 2001 |
|
RU2269784C2 |
| NEW PEPTIDE INVOLVED IN ENERGY HOMEOSTASIS | 2006 |
|
RU2409590C2 |
